Aortoesophageal fistula is a rare and serious condition that carries a high mortality rate. We present a case of overt gastrointestinal bleeding from an aortoesophageal fistula in a patient with chronic infection of an endovascular prosthesis with Coxiella burnetii.
Introduction
Aortoesophageal fistula is a rare and serious condition that carries a high mortality rate. It can occur in patients with thoracic aortic aneurysm who have undergone endovascular repair, especially if vascular graft prosthesis infection is present. 1 Coxiella burnetii, the organism responsible for Q fever, most commonly manifests as culture-negative endocarditis, but can infect vascular graft prostheses, leading to a number of potential complications. Post-operative complications included bilateral pleural effusions (greater on left side) with fluid analysis suggestive of chylothorax (pleural fluid triglyceride 1,233 mg/dL) and paraplegia that was thought to be due to perioperative spinal artery thrombosis, which improved gradually. The patient suffered neurogenic bladder, which required Foley catheter placement and bladder training. She remained in the hospital for 4 weeks and was subsequently discharged in good condition.
Discussion
Aortoenteric fistulas are a rare and deadly cause of gastrointestinal bleeding. Among aortoenteric fistulas, aortoesophageal fistulas account for only 10% of aortoenteric fistulas. 2 Aortoesophageal fistulas most commonly occur in the setting of thoracic aortic aneurysm after thoracic endovascular aortic repair (TEVAR). One study reported a 1.9% incidence of aortoesophageal fistulas in a cohort of patients that underwent TEVAR. Hematemesis and elevated inflammatory markers were associated with aortoesophageal fistulas. CT is the test of choice for diagnosis,although some reports have favored endoscopy. 2, 3 We did not perform endoscopy, as we were concerned about the risk of dislodging a clot with the endoscope, which could precipitate massive bleeding from the aortoesophageal fistula.
Infection is not uncommon in the context of aortoesophageal fistulas in patients with TEVAR, and it is suggested to be the main mechanism of fistula formation. 4 The risk of endograft infection is rare (0.2-0.7%), but commonly associated organisms include methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas spp.
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Coxiella burnetii, the agent responsible for Q fever, has been reported as a cause of vascular infection in several cases, but to our knowledge has not been reported in association with aortoesophageal fistula.
1,7-9
The most common treatment regimen for chronic Q fever infection is doxycycline 100 mg twice daily, and hydroxychloroquine 200 mg 3 times daily. 10, 11 A treatment duration of 18 months has been used for C. burnetii endocarditis, supported by Centers for Disease Control recommendations for vascular infections. 1, 11 Surgical excision of infected graft in addition to antibiotics is an integral part of treatment believed to confer a survival benefit compared to antibiotic treatment alone.
1 Serology studies should be performed monthly during the treatment period. Because of potential retinal toxicity from long-term use of hydroxychloroquine, a baseline ophthalmic examination should be performed before treatment and every 6 months thereafter.
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Aortoesophageal fistula is a rare condition with high mortality rate. Diagnosis requires high index of suspicion and early surgical intervention should be pursued. Presentation with hematemesis should raise concerns for subsequent bleeding, which may be fatal. Endovascular infection with C. burnetii can be difficult to diagnose, and a high level of suspicion is required, particularly in the context of negative blood cultures. Serologic studies should be considered in patients with history of vascular surgery presenting with a febrile illness, especially when a source is not apparent. Successful management of aortoesophageal fistula requires early diagnosis and a multidisciplinary approach with involvement of a surgical team, critical care physicians, and infectious disease physicians. 
